Clinical Implication of 3-vessel Fractional Flow Reserve (FFR)

NCT01621438 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1136

Last updated 2017-08-25

No results posted yet for this study

Summary

This study will evaluate the influence of total atherosclerotic burden assessed by 3-vessel fractional flow reserve (FFR) on the clinical outcomes of the patients with multi-vessel disease. For this purpose, the clinical data of the patients with 3-vessel intermediate coronary artery disease, whose FFR was measured at all 3-vessels due to their own clinical needs, will be analyzed.

Conditions

  • Multivessel Coronary Artery Disease

Sponsors & Collaborators

  • Samsung Medical Center

    collaborator OTHER
  • Keimyung University Dongsan Medical Center

    collaborator OTHER
  • Inje University

    collaborator OTHER
  • Fu Wai Hospital, Beijing, China

    collaborator OTHER
  • The First Affiliated Hospital with Nanjing Medical University

    collaborator OTHER
  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    collaborator OTHER
  • Guangdong Provincial People's Hospital

    collaborator OTHER
  • Tokyo medical college hospital, Japan

    collaborator UNKNOWN
  • Kokura Memorial Hospital

    collaborator OTHER
  • Gifu Heart Center

    collaborator OTHER
  • Aichi Medical University

    collaborator OTHER
  • Wakayama Medical University

    collaborator OTHER
  • Queen Mary Hospital, Hong Kong

    collaborator OTHER
  • United Christian Hospital

    collaborator OTHER
  • National University Heart Centre, Singapore

    collaborator OTHER
  • National Taiwan University Hospital

    collaborator OTHER
  • Nagoya Daini Nesseki Hospital

    collaborator OTHER
  • Ulsan University Hospital

    collaborator OTHER
  • Ajou University School of Medicine

    collaborator OTHER
  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Bon-Kwon Koo, MD · Cardiovascular Center, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul, 110-744, South Korea

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2015-03-31
Completion
2018-09-30

Countries

  • China
  • Japan
  • Singapore
  • South Korea
  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01621438 on ClinicalTrials.gov